SCHEMBL7966061

SCHEMBL7966061

CCOC(Cc1ccc(OCC=C2c3occc3-c3ccoc32)cc1)C(=O)O

nearest known ligand 0.70

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 18/20 0.70
PPARG P37231 12/20 0.70
PPARD Q03181 14/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6739034 0.93 PPARG (0.79) PPARAPPARGPPARD
SCHEMBL6739037 0.93 PPARG (0.79) PPARAPPARGPPARD
SCHEMBL7965108 0.91 PPARA (0.57) PPARAPPARGPPARD
SCHEMBL7968916 0.90 PPARG (0.65) PPARAPPARGPPARD
SCHEMBL7968118 0.89 PPARA (0.54) PPARAPPARGPPARD
SCHEMBL7953586 0.84 PPARA (0.49) PPARAPPARGPPARD
SCHEMBL6735155 0.84 PPARG (0.66) PPARAPPARGPPARD
SCHEMBL6735153 0.84 PPARG (0.66) PPARAPPARGPPARD
SCHEMBL6731786 0.82 PPARA (1.00) PPARAPPARGPPARD
SCHEMBL6736232 0.81 PPARA (0.91) PPARAPPARGPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6300339-B1 USEFUL FOR THRERAPY AND/OR PROPHYLAXIS OF INSULIN RESISTANCE (TYPE 2 DIABETES), IMPAIRED GLUCOSE TOLERANCE, DYSLIPIDEMIA, HYPERTENSION, OBESITY, INSULIN RESISTANCE, HYPERGLYCEMIA, ATHEROSCLEROSIS, HYPERLIPIDEMIA, CORONARY ARTERY DISEASE NOVO NORDISK A/S (DK) 2001-10-09 US disclosed